| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/24/2001 | US6265183 Direct molecular cloning of foreign genes into poxviruses and methods for the preparation of recombinant proteins |
| 07/24/2001 | US6265174 Methods and compositions for identifying and modulating ctionprotein-interactions |
| 07/24/2001 | US6265173 Methods of modulating the expression of genes using ultraspiracle receptor |
| 07/24/2001 | US6265160 Method of identifying inhibitors of the Jak-Stat signal transduction pathway |
| 07/24/2001 | US6265158 Nucleotide sequences associated with genetic disorders; for the detection and diagnosis of preferential genetic disorders |
| 07/24/2001 | US6265157 Screening humans for genetic disorders; isolate mutant nucleotide sequences and compare to wild tpye sequences, an adjustment in nucleotide sequences indicates genetic disorders |
| 07/24/2001 | US6265149 Screening sample for preferential immunological complexes; incubate sample with antigen, incubate sample with control, monitor complexes formed, count complexes in samples, more complexes in antigen sample indicates presence of retrovirus |
| 07/24/2001 | US6264958 Polynucleotide |
| 07/24/2001 | US6264957 Product of infectious respiratory syncytial virus from cloned nucleotide sequences |
| 07/24/2001 | US6264955 Ferrichrome transport ATP-binding protein |
| 07/24/2001 | US6264954 Immunogenic peptide |
| 07/24/2001 | US6264953 Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
| 07/24/2001 | US6264951 Administering polypeptide |
| 07/24/2001 | US6264950 Complex of protein and immunoglobulin |
| 07/24/2001 | US6264942 Bacillus thuringiensis containing compositions |
| 07/24/2001 | US6264941 Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 07/24/2001 | CA2296869A1 A surface-exposed lipoprotein to campylobacter jejuni involved in adherence to hep-2 cells |
| 07/24/2001 | CA2205006C Modified green fluorescent proteins |
| 07/24/2001 | CA2191844C Acylated enol derivatives as prodrugs of elastase inhibitors |
| 07/24/2001 | CA2085465C Thrombin inhibitors based on the amino acid sequence of hirudin |
| 07/24/2001 | CA2065299C Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 07/24/2001 | CA2058676C Process for isolating human albumin from supernatant iv, in particular iv-4, or from cohn's fraction v or from an analogous supernatant or fraction |
| 07/24/2001 | CA2040810C Process for producing foreign proteins in streptomyces |
| 07/24/2001 | CA2033355C Cloning host organisms |
| 07/24/2001 | CA2027936C Cyclic anti-aggregatory peptides |
| 07/24/2001 | CA2024629C Xenopus laevis bone morphogenic protein, dna encoding same and use thereof |
| 07/19/2001 | WO2001051673A1 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
| 07/19/2001 | WO2001051672A2 System and method for controlling male fertility |
| 07/19/2001 | WO2001051666A1 Methods for diagnosing and treating heart disease |
| 07/19/2001 | WO2001051653A1 Pcr-based detection of rhizoctonia cerealis |
| 07/19/2001 | WO2001051645A1 Obg3 globular head and uses thereof for decreasing body mass |
| 07/19/2001 | WO2001051642A2 Dna modification proteins |
| 07/19/2001 | WO2001051637A1 Specific fruit- plant promoter |
| 07/19/2001 | WO2001051636A2 Secreted proteins |
| 07/19/2001 | WO2001051635A2 Novel stra6 polypeptides |
| 07/19/2001 | WO2001051634A1 Human olfactory receptor and polynucleotides encoding the same |
| 07/19/2001 | WO2001051633A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 07/19/2001 | WO2001051632A2 Odorant receptor polypeptides and nucleic acids encoding same |
| 07/19/2001 | WO2001051631A2 Regulatory sequence for the specific expression in dendritic cells and uses thereof |
| 07/19/2001 | WO2001051628A2 Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| 07/19/2001 | WO2001051627A2 Soybean cyst nematode (scn) resistance loci rhg1 and rhg4 |
| 07/19/2001 | WO2001051611A1 Cell production |
| 07/19/2001 | WO2001051610A1 Ectoderm cell production |
| 07/19/2001 | WO2001051609A1 Isolation and in vitro differentiation of conditionally immortalized murine olfactory receptor neurons |
| 07/19/2001 | WO2001051607A1 Quantification of cellular injury using expression of a fluorescent protein under the control of the gadd153 promoter |
| 07/19/2001 | WO2001051523A2 Anti-angiogenic proteins and fragments and methods of use thereof |
| 07/19/2001 | WO2001051521A2 Methods of identifying modulators of the fgf receptor |
| 07/19/2001 | WO2001051520A2 Nogo receptor-mediated blockade of axonal growth |
| 07/19/2001 | WO2001051519A2 Potassium channel mutants of the saccharomyces cerevisiae yeast and the use thereof for the screening of eukaryotic potassium channels |
| 07/19/2001 | WO2001051518A2 Nucleic acids encoding human semaphorin proteins and use thereof |
| 07/19/2001 | WO2001051517A2 Candida hemolysin - like proteins and their uses |
| 07/19/2001 | WO2001051516A2 Fusion proteins for stimulating cytotoxic t-cells |
| 07/19/2001 | WO2001051515A2 Genes differentially expressed in breast cancer |
| 07/19/2001 | WO2001051514A1 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 07/19/2001 | WO2001051513A2 Ovarian tumor-associated sequences |
| 07/19/2001 | WO2001051512A2 Human and parasite orphan receptor proteins |
| 07/19/2001 | WO2001051511A2 Recombinant production of human histone-1 subtypes and use thereof for therapeutic purposes |
| 07/19/2001 | WO2001051510A2 G-csf conjugates |
| 07/19/2001 | WO2001051509A2 Shc-associated protein 140 (sap-140) |
| 07/19/2001 | WO2001051506A2 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides |
| 07/19/2001 | WO2001051504A1 71 human secreted proteins |
| 07/19/2001 | WO2001051081A1 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| 07/19/2001 | WO2001051078A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia |
| 07/19/2001 | WO2001051045A2 Modulators of the constitutive adrostane receptor (car): screening and treatment of hypercholesterolemia |
| 07/19/2001 | WO2001051006A2 Cardiac-cell specific enhancer elements and uses thereof |
| 07/19/2001 | WO2001050829A2 Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| 07/19/2001 | WO2001014414A3 Human abc2 transporter and uses thereof |
| 07/19/2001 | WO2001005969A3 Electron transfer proteins |
| 07/19/2001 | WO2001005820A3 Method for down-regulating gdf-8 activity |
| 07/19/2001 | WO2001005757A3 Process for the deprotection of protected thiols |
| 07/19/2001 | WO2001005418A3 Tissue regenerating agent |
| 07/19/2001 | WO2001005353A3 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 07/19/2001 | WO2001004297A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 07/19/2001 | WO2001004271A3 Respiratory syncytial viruses expressing immune modulatory molecules |
| 07/19/2001 | WO2001002549A3 Homomeric and heteromeric ampa receptors |
| 07/19/2001 | WO2001002424A3 Peptide boronic acid inhibitors of hepatitis c virus protease |
| 07/19/2001 | WO2001000844A3 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 07/19/2001 | WO2000078813A3 Huntington disease cellular model: stably transfected pc12 cells expressing mutant huntingtin |
| 07/19/2001 | WO2000077043A3 Dna vaccines for pets and sport animals |
| 07/19/2001 | WO2000073431B1 Methods and compositions for measuring ion channel conductance |
| 07/19/2001 | WO2000073324A3 Modulation of gene expression in gastrointestinal inflammation |
| 07/19/2001 | WO2000071716A3 Vascular endothelial growth factor dimers |
| 07/19/2001 | WO2000069891A3 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 07/19/2001 | WO2000065053A3 Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma |
| 07/19/2001 | WO2000065040A3 Cell cycle genes from plants and methods of use |
| 07/19/2001 | WO2000055321B1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 07/19/2001 | WO2000044782A3 Ewing's tumour antigen, nucleic acid and antibodies |
| 07/19/2001 | WO2000041474A3 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/19/2001 | WO2000039280A3 Leukocyte-derived interferon preparations |
| 07/19/2001 | WO2000031136A9 Antagonistic analogs of gh-rh inhibiting igf-i and -ii |
| 07/19/2001 | WO2000023573A9 Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies |
| 07/19/2001 | WO1999047934A3 Early pregnancy diagnosis using pags (pregnancy-associated glycoproteins) |
| 07/19/2001 | WO1998033916A8 Secreted proteins and polynucleotides encoding them |
| 07/19/2001 | US20010008936 Oligonucleotides having chiral phosphorus linkages |
| 07/19/2001 | US20010008934 Stablity; useful in drugs, vaccines, personal care/cosmetics, veterinary drugs/vaccines, foods, feeds, diagnostics, cleaning agents (detergents and decontaminants); catalytic and binding components of biosensors |
| 07/19/2001 | US20010008887 Incubating sample under sufficient conditions to enrich target pathogen population in sample, immunoselecting target pathogen from sample, amplifying nucleic acid sequences specific to target pathogen |
| 07/19/2001 | US20010008764 Heparin binding protein |
| 07/19/2001 | US20010008759 Contacting target cells with member of antibody phage display library |
| 07/19/2001 | US20010008627 Controlling cell accumulation |
| 07/19/2001 | CA2406722A1 Dna modification proteins |